WASHINGTON, May 8 (Reuters) – Frustrated abortion opponents \u200cmet with White House officials on Friday amid growing criticism in the anti-abortion movement that President Donald Trump has not moved aggressively enough to advance key priorities, including new restrictions and stronger enforcement.<\/p>\n\n\n\n
The guest list for the meeting was not disclosed but Susan B. Anthony Pro-Life America said its influential president, \u200bMarjorie Dannenfelser, attended.<\/p>\n\n\n\n
“Marjorie had a very constructive meeting at the White House today,” said Kelsey Pritchard, a spokesperson for \u200bthe group.<\/p>\n\n\n\n
Earlier this week Dannenfelser told the Wall Street Journal that abortions have risen in the United \u2060States since the Supreme Court overturned Roe v. Wade in 2022, adding that “Trump is the problem.”<\/p>\n\n\n\n
Tensions have grown between Trump and parts \u200bof the anti-abortion movement that were among his strongest political allies during his first presidential campaign.<\/p>\n\n\n\n
While activists credit Trump for helping \u200boverturn Roe v. Wade through his Supreme Court appointments, some groups say the administration has not followed through with aggressive federal action to curb abortion access, including tighter restrictions on the abortion pill mifepristone and enforcement against online pill distributors.<\/p>\n\n\n\n
Since Roe’s overturning, Trump has repeatedly said abortion \u200bpolicy should be decided by individual states.<\/p>\n\n\n\n
White House spokeswoman Allison Schuster defended the administration’s record.<\/p>\n\n\n\n
“President Trump is the most pro-life \u200band pro-family president in American history, and his Administration has announced a series of bold actions to safeguard life and uphold Americans’ fundamental \u200cfreedoms, \u2060including ending federal funding of abortion abroad,” Schuster said in a statement.<\/p>\n\n\n\n
Data from the Guttmacher Institute, a research group, show abortions have risen since the Supreme Court’s 2022 ruling overturning its decision making abortion legal nationwide, with an estimated 1,126,000 provided by clinicians in 2025, the highest since 2009, driven largely by the expanded use of abortion pills, which now account for \u200b65% of abortions in states \u200bwhere the procedure is legal.<\/p>\n\n\n\n
The \u2060pressure campaign has intensified in recent months as Republican lawmakers and anti-abortion groups push the Food and Drug Administration to revisit safety rules surrounding mifepristone, which is used in more than \u200bhalf of U.S. abortions. Senate Republicans in March launched a probe into abortion pill \u200bmanufacturers and urged \u2060the Food and Drug Administration to crack down on online sales of the drug.<\/p>\n\n\n\n
The White House signed off on a plan to fire FDA Commissioner Marty Makary, sources familiar with the matter said on Friday. Makary has been under growing pressure to produce a safety review of \u2060mifepristone \u200band Dannenfelser renewed her call this week to fire him.<\/p>\n\n\n\n
The debate over abortion \u200bmedication has escalated following a series of court rulings over mail-order access to mifepristone.<\/p>\n\n\n\n
This week, the U.S. Supreme Court temporarily restored access to the drug \u200bthrough telemedicine and mail delivery while litigation continues.<\/p>\n\n\n\n